The FDA has approved a companion diagnostic to determine if patients with HR-positive, HER2-ultralow metastatic breast cancer are eligible for T-DXd treatment.
UCU members protested outside the Senedd today in opposition to proposed cuts at Cardiff University. Last week, it was ...
New Nurses - AXN White, 05.02. - Dänemark in den 50er-Jahren: Aufgrund des Mangels an ausgebildeten Krankenschwestern ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback